1256360-26-5 Usage
Uses
Used in Organic Synthesis:
N-(2-Methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetamide is used as a reagent for forming carbon-carbon and carbon-heteroatom bonds, facilitating the synthesis of complex organic molecules.
Used in Medicinal Chemistry:
In the pharmaceutical industry, N-(2-Methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetamide is used as a building block for the development of new drugs, owing to its potential pharmacological properties.
Used as an Anti-Inflammatory Agent:
N-(2-Methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetamide is studied for its potential as an anti-inflammatory agent, which could be utilized in the treatment of various inflammatory conditions.
Used as an Anti-Cancer Agent:
N-(2-Methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetamide is also being investigated for its anti-cancer properties, with potential applications in the development of novel therapeutics for cancer treatment.
Used in Selective Complexation:
Due to its boronic acid functionality, N-(2-Methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetamide is used for selective complexation with certain biological substrates, which can be applied in various biochemical and diagnostic assays.
Check Digit Verification of cas no
The CAS Registry Mumber 1256360-26-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,5,6,3,6 and 0 respectively; the second part has 2 digits, 2 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1256360-26:
(9*1)+(8*2)+(7*5)+(6*6)+(5*3)+(4*6)+(3*0)+(2*2)+(1*6)=145
145 % 10 = 5
So 1256360-26-5 is a valid CAS Registry Number.
1256360-26-5Relevant academic research and scientific papers
1,2,4-TRIAZINE-4-AMINE DERIVATIVES
-
, (2011/09/14)
According to the invention there is provided a compound of formula A1 which may be useful in the treatment of a condition or disorder ameliorated by the inhibition of the A1- A2b or, particularly, the A2a receptor wherein the compound of formula A1 has the structure, wherein, A represents Cy1 or HetA; Cy1 represents a 5- to 14-membered aromatic, fully saturated or partially unsaturated carbocyclic ring system comprising one, two or three rings, which Cy1 group is optionally substituted by one or more R4a substituents; HetA represents a 5- to 14-membered heterocyclic group that may be aromatic, fully saturated or partially unsaturated, and which contains one or more heteroatoms selected from O, S and N, which heterocyclic group may comprise one, two or three rings and which HetA group is optionally substituted by one or more R4b substituents; B represents a Cy2 or HetB; Cy2 represents a 3- to 10-membered aromatic, fully saturated or partially unsaturated carbocyclic ring system comprising one or two rings, which Cy2 group is optionally substituted by one or more R4c substituents; HetB represents a 3- to 10-membered heterocyclic group that may be aromatic, fully saturated or partially unsaturated, and which contains one or more heteroatoms selected from O, S and N, which heterocyclic group may comprise one or two rings and which HetB group is optionally substituted by one or more R4d substituents.
